An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. [electronic resource]
- Clinical neuropharmacology Aug 1996
- 341-8 p. digital
Publication Type: Clinical Trial; Journal Article
0362-5664
10.1097/00002826-199619040-00007 doi
Adult Dose-Response Relationship, Drug Famotidine--therapeutic use Female Humans Male Middle Aged Prognosis Psychiatric Status Rating Scales Schizophrenia--drug therapy Schizophrenic Psychology